Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Colorectal Cancer
Related studies linked through entity extraction aliases.
Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Donafenib for Previously Treated Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Special Combination of BBI608 and Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Chemotherapy-related Toxicity, Nutritional Status and Quality of Life
- Status
- UNKNOWN
- Phase
- NA
Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- N/A
Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC
- Status
- COMPLETED
- Phase
- PHASE2
Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study for Validation of Immunological Biomarkers in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- NA
A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Pemetrexed and Erlotinib for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With Chemotherapy Combined With Bevacizumab
- Status
- COMPLETED
- Phase
- N/A
Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Perindopril and Regorafenib in mCRC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line
- Status
- COMPLETED
- Phase
- N/A
Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line Treatment
- Status
- UNKNOWN
- Phase
- PHASE2